Advertisement

Topics

BioPortfolio Blog about Biotechnology, Pharmaceutical and Healthcare

03:17 EST 19th January 2019 | BioPortfolio

Updates and info from the contributors bringing you BioPortfolio.com.

Showing News Articles 1–5 of 40,000+

Friday 18th January 2019

WiskottAldrich Syndrome Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

WiskottAldrich Syndrome Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, WiskottAldrich Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of WiskottAldrich Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on WiskottAldrich Syndrome. Report includes an overview of trial numbers and their avera...

Thursday 17th January 2019

Carena Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryCarena Inc Carena is a telemedicine solution provider that serves patients through phone, webcam, or house call to diagnose and treat injuries and illness. The center provides virtual house call and inhome care services integrated with other company sponsored health and productivity initiatives such as nurse lines, wellness programs, and care management, and followingup with member's primar...

KOL Perspectives: Perceptions of recent upcoming data for key HBV pipeline agents [Report Updated: 02102018] Prices from USD $2500

KOL Perspectives: Perceptions of recent upcoming data for key HBV pipeline agentsSummaryThis KOL Insight briefing focuses on KOLs views of recent upcoming data for key HBV pipeline agents.Questions topics Further Phase I data required for Roche's capsid inhibitor RO7049389 Replicor's US trial plans and transition from IV to subcutaneous REP 2139 Efficacy of Spring Bank's inarigivir at 100mg in...

Wednesday 16th January 2019

XLinked Agammaglobulinemia Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

XLinked Agammaglobulinemia Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, XLinked Agammaglobulinemia Global Clinical Trials Review, H2, 2018" provides an overview of XLinked Agammaglobulinemia clinical trials scenario. This report provides top line data relating to the clinical trials on XLinked Agammaglobulinemia. Report includes an overview of trial numbers and...

Mexico Fetal Monitors Market Outlook to 2025 [Report Updated: 01122018] Prices from USD $4995

Mexico Fetal Monitors Market Outlook to 2025SummaryGlobalData's new report, Mexico Fetal Monitors Market Outlook to 2025, provides key market data on the Mexico Fetal Monitors market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Antepartum Monitors and Intrapartum Monitors.The report also provides company shares and distributi...


Advertisement
Quick Search
Advertisement
Advertisement